Skip to main content
Publications
Cook C, Carrico J, Talbird S , Gountas I, Skroumpelos A, Boutselakou E, Trimis G, Sabale U, Bencina G. Public health and economic impact of pediatric immunization program in Greece . Presented at the 42nd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) 2024; May 24, 2024. Copenhagen, Denmark.
Barbieri M, Senese F, Mellott CE, Boccalini S, Carrico J, Bechini A, Talbird SE , Chen Y-H, Bencina G. Public health impact and return on investment of the pediatric national immunization program in Italy . Presented at the Italian Society of Hygiene, Preventive Medicine, and Public Health Conference; October 12, 2023. Cernobbio, Italy.
Talbird S , Graham J , Anderson S , Nossov M, Beattie N, Lains Sousa C, Rak A, Masters III H, Diaz-Mitoma F. Cost-effectiveness and epidemiological impact of a novel 3-antigen vaccine for the prevention of Hepatitis B in adults in the United Kingdom . Poster presented at the ISPOR Europe 2022; November 8, 2022. Vienna, Austria. doi: 10.1016/j.jval.2022.09.782
Savatt JA, Azzariti DR, Faucett A, Florin J, Ledbetter DH, Rangel Miller V, Palen E, Rehm HL, Rhode J, Rogers L, Talbird S , Trutoiu L, Vidal JA, Waggoner C, Rooney Riggs E, Lese Martin C. Expanding patient data sharing: GenomeConnect's pilot to engage external registries in data sharing . Poster presented at the 2019 National Society of Genetic Counselors (NSGC) 38th Annual Conference; November 2019. Salt Lake City, UT.
Savatt JM, Azzariti DR, Faucett WA, Ledbetter DH, Rangel Miller V, Palen E, Rehm HL, Rhode J, Rogers L, Talbird S , Trutoiu L, Vidal JA, Rooney Riggs E, Lese Martin C. ClinGen's patient data sharing program: leveraging data sharing experience from GenomeConnect to broaden patient data sharing efforts . Poster presented at the 2019 Curating the Clinical Genome Conference; May 2019. Washington, DC.
Myers RP, Brogan AJ , Talbird SE , Thompson J, Marcellin P, Jacobson IM, DeMasi R, Menzie AM, Yoshida EM. Efficacy, safety, and cost-effectiveness in Canada of telaprevir combination therapy by baseline fibrosis stage in treatment-naïve patients with chronic genotype 1 hepatitis C virus infection . Presented at the 2013 Canadian Digestive Diseases Week and the Annual Winter Meeting of the Canadian Association for the Study of the Liver; March 2013.